Literature DB >> 1587398

Prospective analysis of the insulin-resistance syndrome (syndrome X).

S M Haffner1, R A Valdez, H P Hazuda, B D Mitchell, P A Morales, M P Stern.   

Abstract

Many studies have shown that hyperinsulinemia and/or insulin resistance are related to various metabolic and physiological disorders including hypertension, dyslipidemia, and non-insulin-dependent diabetes mellitus. This syndrome has been termed Syndrome X. An important limitation of previous studies has been that they all have been cross sectional, and thus the presence of insulin resistance could be a consequence of the underlying metabolic disorders rather than its cause. We examined the relationship of fasting insulin concentration (as an indicator of insulin resistance) to the incidence of multiple metabolic abnormalities in the 8-yr follow-up of the cohort enrolled in the San Antonio Heart Study, a population-based study of diabetes and cardiovascular disease in Mexican Americans and non-Hispanic whites. In univariate analyses, fasting insulin was related to the incidence of the following conditions: hypertension, decreased high-density lipoprotein cholesterol concentration, increased triglyceride concentration, and non-insulin-dependent diabetes mellitus. Hyperinsulinemia was not related to increased low-density lipoprotein or total cholesterol concentration. In multivariate analyses, after adjustment for obesity and body fat distribution, fasting insulin continued to be significantly related to the incidence of decreased high-density lipoprotein cholesterol and increased triglyceride concentrations and to the incidence of non-insulin-dependent diabetes mellitus. Baseline insulin concentrations were higher in subjects who subsequently developed multiple metabolic disorders. These results were not attributable to differences in baseline obesity and were similar in Mexican Americans and non-Hispanic whites. These results support the existence of a metabolic syndrome and the relationship of that syndrome to multiple metabolic disorders by showing that elevations of insulin concentration precede the development of numerous metabolic disorders.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587398     DOI: 10.2337/diab.41.6.715

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  179 in total

Review 1.  Obesity and hypertension.

Authors:  E Faloia; G Giacchetti; F Mantero
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

Review 2.  Genetic determinants of diabetes and atherosclerosis.

Authors:  Braxton D Mitchell; Ikhide G Imumorin
Journal:  Curr Atheroscler Rep       Date:  2002-05       Impact factor: 5.113

Review 3.  Cardiovascular risk associated with the metabolic syndrome.

Authors:  Robert S Lindsay; Barbara V Howard
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

4.  Prevalence, components, and correlates of metabolic syndrome (MetS) among elderly Muscovites.

Authors:  Victoria A Metelskaya; Maria A Shkolnikova; Svetlana A Shalnova; Evgeny M Andreev; Alexander D Deev; Dmitri A Jdanov; Vladimir M Shkolnikov; James W Vaupel
Journal:  Arch Gerontol Geriatr       Date:  2011-09-28       Impact factor: 3.250

5.  Impaired-inactivation of FoxO1 contributes to glucose-mediated increases in serum very low-density lipoprotein.

Authors:  Ke Wu; David Cappel; Melissa Martinez; John M Stafford
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

6.  Homeostasis model assessment of insulin resistance and the risk of cardiovascular events in middle-aged non-diabetic Japanese men.

Authors:  K Nakamura; M Sakurai; K Miura; Y Morikawa; M Ishizaki; K Yoshita; T Kido; Y Naruse; H Nakagawa
Journal:  Diabetologia       Date:  2010-05-26       Impact factor: 10.122

7.  Genome-wide scans for heritability of fasting serum insulin and glucose concentrations in hypertensive families.

Authors:  B I Freedman; S S Rich; M M Sale; G Heiss; L Djoussé; J S Pankow; M A Province; D C Rao; C E Lewis; Y D I Chen; S R Beck
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

Review 8.  The effect of in-utero undernutrition on the insulin resistance syndrome.

Authors:  Delphine Jaquet; Juliane Leger; Paul Czernichow; Claire Levy-Marchal
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

9.  Bivariate genome-wide scan for metabolic phenotypes in non-diabetic Chinese individuals from the Stanford, Asia and Pacific Program of Hypertension and Insulin Resistance Family Study.

Authors:  Y-F Chiu; L-M Chuang; H-Y Kao; L-T Ho; C-T Ting; Y-J Hung; Y-D Chen; T Donlon; J D Curb; T Quertermous; C A Hsiung
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

Review 10.  Anti-hypertensive drug treatment of patients with and the metabolic syndrome and obesity: a review of evidence, meta-analysis, post hoc and guidelines publications.

Authors:  Jonathan G Owen; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-06       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.